Veristat Strengthens Biostatistics, Drug Development Advisory, and People Leadership to Support Growth in Complex Clinical Development

Contributed by: Business Wire

Logo

Tags

Consulting

Biotechnology

Technology

Professional Services

Other Health

Health

Pharmaceutical

Oncology

Research

Artificial Intelligence

Science

Veristat

More Like This

Veristat Acquires Biometrics-focused Instat Clinical Research

Veristat Launches AI Biostatistics Platform, Cutting Clinical Trial Data Readout Time from 5 Weeks to 5 Days* Without Regulatory Risks

Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues Impacting the Advanced Therapy Sector

Rachel Page, Chief Commercial Officer, Veristat (Photo: Business Wire)

Veristat Appoints New Chief Commercial Officer

Veristat to Acquire Certara’s Regulatory and Medical Writing Business

Gabriela Rosu, MD Senior Director, Global Medical Affairs Veristat (Photo: Business Wire)

Veristat Appoints Gabriela Rosu, M.D., to Lead Growing Medical Affairs Team

PR Newswire associated0

HistoIndex Charts New Course in Liver Disease Innovation: Announces Pivotal Changes to Scientific Advisory Board

Exscientia Appoints New Leaders to Strengthen the Impact of Integrated Technologies and Focus Clinical Development Expertise in Oncology